imd BIOTECH
imd BIOTECH GmbH is dedicated to revolutionizing food safety testing through its innovative raPPid platform, which offers rapid, accurate, and easy-to-use pathogen detection solutions. Their mission is to significantly elevate food safety standards and protect public health by providing faster results with high specificity and sensitivity across various application areas including food & feed safety, veterinary care, and healthcare.
Industries
Nr. of Employees
small (1-50)
Products
Universal rapid pathogen identification platform
Integrated platform combining pathogen-specific biosensors, automated analyzer hardware, and continuous measurement software to enable faster pathogen identification across food, feed, veterinary and point-of-care settings.
Universal rapid pathogen identification platform
Integrated platform combining pathogen-specific biosensors, automated analyzer hardware, and continuous measurement software to enable faster pathogen identification across food, feed, veterinary and point-of-care settings.
Services
Collaborative pilot tests with customers to evaluate system performance and validate assays in operational settings.
Collaborative pilot tests with customers to evaluate system performance and validate assays in operational settings.
Expertise Areas
- Food pathogen testing
- Veterinary diagnostics
- Point-of-care diagnostic testing
- Biosensor development
Key Technologies
- Biosensor-based detection
- Automated analyzer instruments
- Continuous real-time monitoring software
- Molecular/microorganism detection assays
News & Updates
imd BIOTECH announces first tests with pilot customers to start in Q2/2025.
A listeriosis outbreak connected to supplemental milkshakes in healthcare facilities has resulted in 38 illnesses and 12 deaths across 21 states, highlighting the critical need for rapid pathogen detection.
imd BIOTECH announces first tests with pilot customers to start in Q2/2025.
A listeriosis outbreak connected to supplemental milkshakes in healthcare facilities has resulted in 38 illnesses and 12 deaths across 21 states, highlighting the critical need for rapid pathogen detection.